Modern trends in minimally invasive versus open hepatectomy for colorectal liver metastasis: an analysis of ACS-NSQIP
Carpenter, E. L., Thomas, K. K., Adams, A. M., Valdera, F. A., Chick, R. C., Kemp Bohan, P. M., Spitzer, H. V., Clifton, G. T., Bader, J. O., Nelson, D. W., Vreeland, T. J.
Published in Surgical endoscopy (01.07.2023)
Published in Surgical endoscopy (01.07.2023)
Get full text
Journal Article
Using the Flipped Classroom Model in Surgical Education: Efficacy and Trainee Perception
Chick, RC, Adams, AM, Peace, KM, Kemp Bohan, PM, Schwantes, IR, Clifton, GT, Vicente, D, Propper, B, Newhook, T, Grubbs, EG, Bednarski, BK, Vreeland, TJ
Published in Journal of surgical education (01.11.2021)
Published in Journal of surgical education (01.11.2021)
Get full text
Journal Article
Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development
Berry, J S, Vreeland, T J, Hale, D F, Jackson, D O, Trappey, A F, Greene, J M, Hardin, M O, Herbert, G S, Clifton, G T, Peoples, G E
Published in Journal of Cancer (01.01.2017)
Published in Journal of Cancer (01.01.2017)
Get full text
Journal Article
Pre-specified interim analysis of a randomized phase IIb trial of trastuzumab + nelipeptimut-S (NeuVax) vs trastuzumab for the prevention of recurrence demonstrates benefit in triple negative (HER2 low-expressing) breast cancer patients
Hale, D.F., Mittendorf, E.A., Brown, T.A., Clifton, G.T., Vreeland, T.J., Myers, J., Peace, K., Jackson, D., Greene, J., Holmes, J., Peoples, G.E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1128OPre-specified interim analysis of a randomized phase IIb trial of trastuzumab + nelipeptimut-S (NeuVax) vs trastuzumab for the prevention of recurrence demonstrates benefit in triple negative (HER2 low-expressing) breast cancer patients
Hale, D F, Mittendorf, E A, Brown, T A, Clifton, G T, Vreeland, T J, Myers, J, Peace, K, Jackson, D, Greene, J, Holmes, J, Peoples, G E
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Interim safety analysis of a phase II trial combining trastuzumab and NeuVax, a HER2-targeted peptide vaccine, to prevent breast cancer recurrence in HER2 low expression
Jackson, D.O., Peace, K.M., Hale, D.F., Vreeland, T.J., Choy, G., Nejadnik, B., Greene, J.M., Schneble, E.J., Berry, J.S., Trappey, A.F., Hardin, M.O., Clifton, G.T., Herbert, G.S., Mittendorf, E., Holmes, J.P., Peoples, G.E.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Abstract P2-09-01: Subgroups analysis of a multicenter, prospective, randomized, blinded phase 2b trial of trastuzumab + nelipeptimut-S (NeuVax) vs trastuzumab for prevention of recurrence in breast cancer patients
Clifton, GT, Kemp Bohan, PM, Hale, DF, Myers, JW, Brown, TA, Holmes, JP, Vreeland, TJ, Litton, JK, Murthy, RK, Mittendorf, EA, Peoples, GE
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P6-10-04: Determining the optimal vaccination strategy using a combination of the folate binding protein (FBP) peptide vaccine (E39+GM-CSF) and an attenuated version (E39') to maximize the immunologic response in breast cancer patients
Jackson, DO, Qiao, N, Peace, KM, Hale, DF, Vreeland, TJ, Greene, JM, Berry, JS, Trappey, AF, Clifton, GT, Ibrahim, N, Toms, A, Peoples, GE, Mittendorf, EA
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P2-11-01: Final pre-specified analysis of the phase II trial of the GP2+GM-CSF peptide vaccine in high risk breast cancer patients to prevent recurrence
Greene, JM, Schneble, EJ, Perez, S, Murray, JL, Berry, JS, Trappey, AF, Hale, DF, Vreeland, TJ, Clifton, GT, Ardavanis, A, Litton, JK, Shumway, NM, Papamichail, M, Peoples, GE, Mittendorf, EA
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
OT3-01-18: Combination Immunotherapy with Trastuzumab and the HER2 Vaccine E75 in Low and Intermediate HER2−Expressing Breast Cancer Patients To Prevent Recurrence
Sears, AK, Clifton, GT, Vreeland, TJ, Hale, DF, Ponniah, S, Mittendorf, EA, Peoples, GE
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
Abstract P5-16-02: Final Results of the Phase I/II Trials of the E75 Adjuvant Breast Cancer Vaccine
Vreeland, TJ, Clifton, GT, Hale, DF, Sears, AK, Patil, R, Holmes, JP, Ponniah, S, Mittendorf, EA, Peoples, GE
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Abstract P4-13-05: HLA-A2 is not a prognostic indicator in breast cancer: Implications for cancer vaccine trials
Trappey, AF, Berry, JS, Vreeland, TJ, Guy, CT, Diane, HF, Alan, SK, Erika, SJ, Ferrise, L, Shumway, NM, Papamichail, M, Perez, SA, Ponniah, S, Mittendorf, EA, Peoples, GE
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Abstract P4-13-02: Preliminary results for the phase 1 trial of a dual HER2 peptide cancer vaccine in breast and ovarian cancer patients
Berry, JS, Trappey, AF, Vreeland, TJ, Schneble, EJ, Clifton, GT, Hale, DF, Sears, AK, Ponniah, S, Shumway, NM, Mittendorf, EA, Peoples, GE
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Abstract P2-14-01: Breast cancer patients with HER2 low-expression: An under-recognized group at significant risk for recurrence
Vreeland, TJ, John, BS, Trappey, AF, Schneble, EJ, Hale, DF, Clifton, GT, Shumway, NM, Perez, SA, Papamichail, M, Ponniah, S, Peoples, GE, Mittendorf, EA
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Enhanced adhesion from high energy ion irradiation
Werner, B.T., Vreeland, T., Mendenhall, M.H., Qui, Y., Tombrello, T.A.
Published in Thin solid films (01.01.1983)
Published in Thin solid films (01.01.1983)
Get full text
Journal Article
P1-13-02: Long-Term Clinical Benefit of Adjuvant Breast Cancer Vaccine: 5 Year Efficacy of E75 with Multiple Booster Inoculations
Vreeland, TJ, Clifton, GT, Sears, AK, Hale, DF, Patil, R, Clive, KS, Holmes, JP, Mittendorf, EA, Ponniah, S, Peoples, GE
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
P1-13-01: An Update of a Phase II Trial of the HER2 Peptide AE37 Vaccine in Breast Cancer Patients To Prevent Recurrence
Hale, DF, Perez, S, Sears, AK, Clifton, GT, Vreeland, TJ, Holmes, JP, Ardavanis, A, Pistamaltzian, N, Rellias, G, Ponniah, S, Papamichail, M, Peoples, GE, Mittendorf, EA
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
Abstract P5-16-05: The combination of trastuzumab and HER2-directed peptide vaccines is safe in HER2-expressing breast cancer patients
Hale, DF, Vreeland, TJ, Perez, SA, Berry, JS, Ardavanis, A, Trappey, AF, Tzonis, P, Sears, AK, Clifton, GT, Shumway, NM, Papamichail, M, Ponniah, S, Peoples, GE, Mittendorf, EA
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article